States Bury Hatchet With TAP Over Drug Pricing

Law360, New York (July 25, 2007, 12:00 AM EDT) -- In a boost for TAP Pharmaceutical Products Inc., the states of Montana and Nevada have asked a federal judge to sign off on a settlement that would toss the company from a massive antitrust class action alleging that a spate of drug makers defrauded consumers by artificially inflating the prices of various prescription medications.

The two states said in court documents filed July 24 that U.S. District Judge Patti B. Saris should dismiss TAP, a subsidiary of Abbott Laboratories and Takeda Pharmaceutical Co. Ltd, from the...
To view the full article, register now.